Stock Analysis of Baudax Bio Inc (BXRX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code BXRX
Close 0.0100
Change -0.0118 / 54.13 %
Volume 69166.00
Vol Change -241706.00 / 77.75 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Very Low Growth Stock
Value Index Mild Value
Profitability Index Mild Profitability
Stability Index Excellent Stability


Fundamental View of Baudax Bio Inc


Highs/Lows of Baudax Bio Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0218 54.13 % 2.10 % 0.01070.0130-Apr-2430-Apr-24
Two Week0.0218 54.13 % 3.59 % 0.01070.0130-Apr-2430-Apr-24
One Month0.0218 54.13 % 3.20 % 0.01070.0130-Apr-2430-Apr-24
Three Month0.0243 58.85 % 6.96 % 0.0280.0115-Feb-2430-Apr-24
Six Months0.184 94.57 % 15.98 % 0.250.0106-Nov-2330-Apr-24
One year0.768 98.70 % 24.12 % 1.20420.0103-Jul-2330-Apr-24
Two year61.1988 99.98 % 48.94 % 37.71830.0126-Aug-2230-Apr-24


Technical View of Baudax Bio Inc






Charts of Baudax Bio Inc


Returns of Baudax Bio Inc with Peers
Period / StockBXRXBTTXIMPLMOTS
1 Week-54.13%-17.27%-50.00%-56.35%
1 Mth-54.13%-16.51%-50.00%-10.53%
3 Mth-58.85%-95.47%-92.85%-88.83%
6mth-94.57%-95.99%-98.15%-98.27%
1 Year-98.70%-98.82%-99.13%-99.39%
2 Year-99.98%-99.42%-99.76%-99.91%
5 Years----99.99%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Baudax Bio Inc with Peers
Ratio / StockBXRXBTTXIMPLMOTS
PE0.0035-3.10-0.882-0.819
P/B-0.0030-32.78-1.9235.34
ROA60.24-296.43-199.53-113.30
ROE000-4313.52
Debt To Equity0000.908
Revenue1269.00 K
0 %
0
%
20987.00 K
65.88 %
364000
38.51 %
Net Income-7154.00 K
87.83 %
-31573.00 K
20.59 %
-74279.00 K
30.13 %
-13744.00 K
26.10 %


Technicals of Baudax Bio Inc with Peers
Technical / StockBXRXBTTXIMPLMOTS-
ADX25.4311.2131.2236.62
CMF-0.0123-0.4440.103-0.482
MFI4.3044.1154.0840.82
RSI30.3640.4830.7729.23
MACD Abv SignalFalseTrueFalseTrue
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Baudax Bio Inc


Address : 490 Lapp Road, Malvern, PA, United States, 19355
Tel : 484 395 2440
URL : https://www.baudaxbio.com
Code : BXRX, ISIN : US07160F2065, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 22_Nov_2019
Employee Count : 9

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.


Note : All Data Generated at the End of Trading Hours (EOD Data)